Weiss Multi-Strategy Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-29,375
| Closed | -$12M | – | 470 |
|
|
2023
Q4 | $12M | Sell |
29,375
-12,223
| -29% | -$4.52M | 0.29% | 82 |
|
|
2023
Q3 | $14.5M | Sell |
41,598
-17,120
| -29% | -$5.99M | 0.34% | 74 |
|
|
2023
Q2 | $20.7M | Sell |
58,718
-6,419
| -10% | -$2.16M | 0.42% | 55 |
|
|
2023
Q1 | $20.5M | Buy |
65,137
+37,235
| +133% | +$11.2M | 0.48% | 47 |
|
|
2022
Q4 | $8.06M | Sell |
27,902
-5,969
| -18% | -$1.82M | 0.23% | 145 |
|
|
2022
Q3 | $9.81M | Sell |
33,871
-6,050
| -15% | -$1.74M | 0.26% | 130 |
|
|
2022
Q2 | $11.2M | Sell |
39,921
-1,579
| -4% | -$423K | 0.34% | 77 |
|
|
2022
Q1 | $10.8M | Sell |
41,500
-3,193
| -7% | -$758K | 0.25% | 139 |
|
|
2021
Q4 | $9.81M | Sell |
44,693
-10,456
| -19% | -$2.03M | 0.22% | 134 |
|
|
2021
Q3 | $10M | Buy |
55,149
+3,124
| +6% | +$610K | 0.22% | 147 |
|
|
2021
Q2 | $10.5M | Buy |
52,025
+2,007
| +4% | +$420K | 0.23% | 139 |
|
|
2021
Q1 | $10.7M | Buy |
50,018
+9,491
| +23% | +$2.08M | 0.24% | 142 |
|
|
2020
Q4 | $9.58M | Buy |
40,527
+3,110
| +8% | +$714K | 0.19% | 157 |
|
|
2020
Q3 | $10.2M | Sell |
37,417
-482
| -1% | -$133K | 0.27% | 124 |
|
|
2020
Q2 | $11M | Buy |
37,899
+1,302
| +4% | +$353K | 0.32% | 99 |
|
|
2020
Q1 | $8.71M | Sell |
36,597
-1,403
| -4% | -$322K | 0.34% | 88 |
|
|
2019
Q4 | $8.32M | Buy |
38,000
+7,000
| +23% | +$1.42M | 0.14% | 212 |
|
|
2019
Q3 | $5.25M | Sell |
31,000
-4,000
| -11% | -$708K | 0.11% | 246 |
|
|
2019
Q2 | $6.42M | Sell |
35,000
-5,000
| -13% | -$874K | 0.17% | 138 |
|
|
2019
Q1 | $7.36M | Hold |
40,000
| – | – | 0.18% | 149 |
|
|
2018
Q4 | $6.63M | Sell |
40,000
-14,208
| -26% | -$2.46M | 0.28% | 99 |
|
|
2018
Q3 | $10.4M | Sell |
54,208
-530
| -1% | -$94.4K | 0.28% | 90 |
|
|
2018
Q2 | $9.3M | Buy |
54,738
+4,738
| +9% | +$734K | 0.22% | 124 |
|
|
2018
Q1 | $8.15M | Sell |
50,000
-1,000
| -2% | -$163K | 0.26% | 105 |
|
|
2017
Q4 | $7.64M | Sell |
51,000
-2,000
| -4% | -$296K | 0.2% | 129 |
|
|
2017
Q3 | $8.06M | Buy |
53,000
+23,826
| +82% | +$3.59M | 0.3% | 93 |
|
|
2017
Q2 | $3.76M | Sell |
29,174
-943
| -3% | -$114K | 0.16% | 193 |
|
|
2017
Q1 | $3.29M | Buy |
30,117
+6,000
| +25% | +$528K | 0.13% | 204 |
|
|
2016
Q4 | $1.78M | Buy |
24,117
+2,526
| +12% | +$206K | 0.09% | 219 |
|
|
2016
Q3 | $1.88M | Sell |
21,591
-426
| -2% | -$40.3K | 0.12% | 226 |
|
|
2016
Q2 | $1.89M | Sell |
22,017
-18,132
| -45% | -$1.57M | 0.15% | 192 |
|
|
2016
Q1 | $3.19M | Sell |
40,149
-18,969
| -32% | -$1.72M | 0.14% | 201 |
|
|
2015
Q4 | $7.44M | Buy |
59,118
+1,004
| +2% | +$121K | 0.51% | 45 |
|
|
2015
Q3 | $6.05M | Buy |
58,114
+30,087
| +107% | +$3.87M | 0.27% | 80 |
|
|
2015
Q2 | $3.46M | Buy |
28,027
+3,027
| +12% | +$381K | 0.14% | 178 |
|
|
2015
Q1 | $2.95M | Buy |
25,000
+15,000
| +150% | +$1.8M | 0.13% | 193 |
|
|
2014
Q4 | $1.19M | Buy |
+10,000
| New | +$1.13M | 0.04% | 263 |
|
|
2014
Q3 | – | Sell |
-5,000
| Closed | -$473K | – | 753 |
|
|
2014
Q2 | $473K | Sell |
5,000
-19,250
| -79% | -$1.35M | 0.01% | 529 |
|
|
2014
Q1 | $1.72M | Buy |
24,250
+3,460
| +17% | +$274K | 0.03% | 379 |
|
|
2013
Q4 | $1.54M | Sell |
20,790
-24,210
| -54% | -$1.69M | 0.03% | 369 |
|
|
2013
Q3 | $3.41M | Buy |
45,000
+10,000
| +29% | +$796K | 0.07% | 276 |
|
|
2013
Q2 | $2.8M | Buy |
+35,000
| New | +$2.58M | 0.08% | 290 |
|
Other funds holding VRTX
Weiss Multi-Strategy Advisers's VRTX Position: Q1 2024 in Review
Weiss Multi-Strategy Advisers sold out of Vertex Pharmaceuticals (VRTX) in Q1 2024, closing a stake of 29,375 shares — an estimated $12M sold.
Weiss Multi-Strategy Advisers first reported a position in VRTX in Q2 2013 and held it in 42 quarters. The position peaked at $20.7M in Q2 2023. 1,493 funds tracked by Wall St. Rank hold VRTX as of Q1 2024.
- Weiss Multi-Strategy Advisers reported no remaining Vertex Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
- Weiss Multi-Strategy Advisers sold 29,375 Vertex Pharmaceuticals shares in Q1 2024, an estimated $12M.
- Weiss Multi-Strategy Advisers first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 42 quarters.
- Weiss Multi-Strategy Advisers's Vertex Pharmaceuticals position peaked at $20.7M in Q2 2023.
- 1,493 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2024.
Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.